CORRECTING and REPLACING St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to ... (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----Please replace the release with the following corrected version due to publication of incorrect Forward-Looking Statements.

Lannett Company Receives FDA Approval For Pilocarpine HCI Tablets 7.5 Mg Strength (Medical News Today)
Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its supplemental Abbreviated New Drug Application (ANDAs) for Pilocarpine HCI tablets, 7.5 mg, the generic equivalent of Salagen , marketed by Eisai Pharmaceuticals.